← Back to Search

Ultrasound Diathermy

Sustained Acoustic Medicine Device Group 1 for Diathermy Mapping

Phase 1
Waitlist Available
Led By George Lewis, PHD
Research Sponsored by ZetrOZ, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• Healthy Volunteer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 - 4 hours
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.

Eligible Conditions
  • Diathermy Mapping

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 - 4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 - 4 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ultrasound Diathermy (Degrees Centigrade)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sustained Acoustic Medicine Device Group 1Experimental Treatment1 Intervention
Patients receive treatment from the SAM Ultrasonic Diathermy Device 1 for 4 hours. The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity.
Group II: Sustained Acoustic Medicine Device Group 2Active Control1 Intervention
Patients receive treatment from the SAM Ultrasonic Diathermy Device 2 for 4 hours. The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sustained Acoustic Medicine
2022
Completed Phase 1
~60

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

ZetrOZ, Inc.Lead Sponsor
16 Previous Clinical Trials
1,271 Total Patients Enrolled
George Lewis, PHDPrincipal InvestigatorZetrOZ, Inc.
~15 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top